HD-OPM Archive
Topics › Supplements & vitamins

Nicotinamide plus pyruvate improved visual-field function in glaucoma in a phase 2 trial

Louis Nervegna · Oct 26, 2026 · ♥ 7 reactions · 1 comments · original Facebook post
Supplements & vitamins
AI summary & key facts

A randomized Columbia University trial tested high-dose nicotinamide (vitamin B3) with pyruvate in patients being treated for open-angle glaucoma. After about two months the supplement group had significantly more improving visual-field locations than placebo, and Louis notes the mechanism likely involves NAD.

The mechanism likely involves NAD.

Link to journal paper:

Paper · Clinical Exper Ophthalmology · 2020Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3 ) supplementation: A crossover randomized clinical trialImportance Retinal ganglion cells endure significant metabolic stress in glaucoma but maintain capacity to recover function. Nicotinamide, a precursor of NAD + , is low in serum of glaucoma patients and its supplementation provides robust protection of retinal ganglion cells in preclinical models. However, the potential of nicotinamide in human glaucoma is unknown. Background To examine the effects of nicotinamide…onlinelibrary.wiley.com

#vitaminb3HD #nicotinamideHD #glaucomaHD

Research cited

Shared from Dr Erickson · original post

Glaucoma damages retinal ganglion cells—the neurons that carry visual information from the eye into the brain through the optic nerve.

In a randomized Phase 2 trial, Columbia University researchers tested high-dose nicotinamide, a form of vitamin B3, together with pyruvate in patients receiving treatment for open-angle glaucoma. After approximately two months, the supplement group showed significantly more improving locations during visual-field testing than the placebo group.

The findings suggest that supporting cellular energy metabolism may temporarily enhance the function of stressed retinal ganglion cells. However, the study did not demonstrate complete optic-nerve restoration or prove that the supplements prevent long-term glaucoma progression.

Only 32 participants completed this small trial, and the doses were considerably higher than those found in ordinary supplements. Patients should not attempt this combination without guidance from an ophthalmologist, especially because it does not replace prescribed pressure-lowering treatment.
Shared for information purpose only.
Reference: PMID: 34792559

May be an image of text
← newer: Taurine lowers age-related inflammation via the NLRP3 inflamolder: Glaucoma neurorecovery review: stressed retinal neurons may →